Wolverine Trading’s SpringWorks Therapeutics SWTX Stock Holding History

Wolverine Trading’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,300	Closed	-$296K	–	6164
2025 Q2	$296K	Sell	6,300 -51,800	-89%	-$2.3M	﹤0.01%	3486
2025 Q1	$2.75M	Buy	+58,100	New	+$2.67M	﹤0.01%	1382

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wolverine Trading's SWTX Position: Q2 2025 in Review

Wolverine Trading sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 19,143 shares — an estimated $852K sold.

Wolverine Trading first reported a position in SWTX in Q1 2025 and held it in 1 quarter. The position peaked at $908K in Q1 2025. 222 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

Wolverine Trading reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
Wolverine Trading sold 19,143 SpringWorks Therapeutics shares in Q2 2025, an estimated $852K.
Wolverine Trading first reported a position in SpringWorks Therapeutics in Q1 2025 and held it in 1 quarter.
Wolverine Trading's SpringWorks Therapeutics position peaked at $908K in Q1 2025.
222 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.